Transmedics
TMDX
373 hedge funds and large institutions have $5.74B invested in Transmedics in 2024 Q3 according to their latest regulatory filings, with 75 funds opening new positions, 137 increasing their positions, 122 reducing their positions, and 41 closing their positions.
83% more first-time investments, than exits
New positions opened: 75 | Existing positions closed: 41
60% more call options, than puts
Call options by funds: $82.4M | Put options by funds: $51.6M
13% more capital invested
Capital invested by funds: $5.09B → $5.74B (+$650M)
12% more repeat investments, than reductions
Existing positions increased: 137 | Existing positions reduced: 122
10% more funds holding
Funds holding: 340 → 373 (+33)
7.3% more ownership
Funds ownership: 102.56% → 109.86% (+7.3%)
33% less funds holding in top 10
Funds holding in top 10: 15 → 10 (-5)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$410M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$165M |
| 3 |
State Street
Boston,
Massachusetts
|
+$75.6M |
| 4 |
1832 Asset Management
Toronto,
Ontario, Canada
|
+$70.2M |
| 5 |
Fidelity International
Hamilton,
Bermuda
|
+$62.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$363M |
| 2 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$70.1M |
| 3 |
Invesco
Atlanta,
Georgia
|
-$41.4M |
| 4 |
D.E. Shaw & Co
New York
|
-$32.4M |
| 5 |
B
Braidwell
Stamford,
Connecticut
|
-$28.6M |
TMDX Hedge Fund Activity: Q3 2024 in Review
373 of the 6,978 institutional investors tracked by Wall St. Rank reported a position in Transmedics (TMDX) for Q3 2024, worth a combined $5.74B — up 13% from $5.09B a quarter earlier.
Buyers outnumbered sellers: 75 funds opened new TMDX positions and 41 closed out — a net gain of 34 holders — while 137 added to existing stakes and 122 trimmed.
The largest buyer was BlackRock, adding an estimated $410M. The largest seller was Fidelity Investments, cutting an estimated $363M.
- 373 institutional investors held Transmedics (TMDX) as of Q3 2024, up from 340 in Q2 2024.
- Funds reported $5.74B of Transmedics stock for Q3 2024, up 13% quarter-over-quarter.
- 75 funds opened new Transmedics positions in Q3 2024 and 41 closed out, a net change of +34 holders.
- The largest Transmedics buyer in Q3 2024 was BlackRock, an estimated $410M added.
- The largest Transmedics seller in Q3 2024 was Fidelity Investments, an estimated $363M sold.
Based on aggregated 13F filings for Q3 2024.